Tarsus Pharmaceuticals Inc.

09/27/2022 | Press release | Distributed by Public on 09/27/2022 10:05

Tarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming[...]